| Robin Gail Spencer, LCPC | |
|
66 Stone St, Augusta, ME 04330-5227 | |
| (207) 626-3455 | |
| (207) 626-3612 |
| Full Name | Robin Gail Spencer |
|---|---|
| Gender | Female |
| Speciality | Counselor - Professional |
| Location | 66 Stone St, Augusta, Maine |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639180060 | NPI | - | NPPES |
| 417110099 | Medicaid | ME |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YP2500X | Counselor - Professional | CC2707 (Maine) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Robin Gail Spencer, LCPC 66 Stone St, Augusta, ME 04330-5227 Ph: (207) 626-3455 | Robin Gail Spencer, LCPC 66 Stone St, Augusta, ME 04330-5227 Ph: (207) 626-3455 |
News Archive
The research team led by Masakazu Ohara, graduate student of the Department of Computer Science and Engineering at Toyohashi University of Technology (student in the Leading Program doctoral program); Associate Professor Kowa Koida of the Electronics-Inspired Interdisciplinary Research Institute; and Associate Professor Juno Kim of the University of New South Wales (Australia) discovered that when people judge the thickness of an object, objects with glass-like transparent optical properties are perceived to be flatter than they actually are.
Muscular dystrophy, which affects approximately 250,000 people in the U.S., occurs when damaged muscle tissue is replaced with fibrous, fatty or bony tissue and loses function. For years, scientists have searched for a way to successfully treat the most common form of the disease, Duchenne Muscular Dystrophy (DMD), which primarily affects boys. Now, a team of University of Missouri researchers have successfully treated dogs with DMD and say that human clinical trials are being planned in the next few years.
The U.S. Food and Drug Administration approved an important new inhaled antibiotic called Cayston® (aztreonam for inhalation solution) today for the treatment of cystic fibrosis. The drug was made possible by significant support from the Cystic Fibrosis Foundation, including a $1 million investment by a Foundation subsidiary to help develop the therapy.
Researchers at Huntsman Cancer Institute at the University of Utah (U of U) discovered in laboratory studies that an experimental drug called selinexor may block a crucial survival pathway exploited by myelofibrosis cells.
UBC researchers have demonstrated that simple, cost-effective email messages can help improve the health habits of Canadians.
› Verified 4 days ago
Amy Curtis, LADC Counselor Medicare: Not Enrolled in Medicare Practice Location: 32 Winthrop St, Augusta, ME 04330 Phone: 207-626-3448 Fax: 207-626-3453 | |
Michelle Ayotte, Counselor Medicare: Not Enrolled in Medicare Practice Location: 147 Riverside Dr Ste 1, Augusta, ME 04330 Phone: 833-356-4080 | |
Penny Kaye Myers, LCPC/C Counselor Medicare: Not Enrolled in Medicare Practice Location: 66 Stone St, Augusta, ME 04330 Phone: 207-313-3455 | |
Robert Michael Long, LCPC/LADC Counselor Medicare: Not Enrolled in Medicare Practice Location: 66 Stone St, Augusta, ME 04330 Phone: 207-626-3455 Fax: 207-626-3612 | |
Rhonda Ann Lawrence, LCPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 49 Oak St, Augusta, ME 04330 Phone: 207-441-9837 Fax: 207-622-6290 | |
Mr. Charles Alexander Iii, LCPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 566 Church Hill Rd, Augusta, ME 04330 Phone: 207-629-7373 | |
Dr. Paul Gervais Gervais, PHD, LCPC, LPC, LMFT Counselor Medicare: Not Enrolled in Medicare Practice Location: 16 Julianne Ln, Augusta, ME 04330 Phone: 207-622-0713 |